Next Article in Journal
Toll-Like Receptor 3 in Solid Cancer and Therapy Resistance
Next Article in Special Issue
Preclinical Rationale for Targeting the PD-1/PD-L1 Axis in Combination with a CD38 Antibody in Multiple Myeloma and Other CD38-Positive Malignancies
Previous Article in Journal
Advances in Acute Myeloid Leukemia: Recently Approved Therapies and Drugs in Development
Previous Article in Special Issue
Targeted Disruption of Bone Marrow Stromal Cell-Derived Gremlin1 Limits Multiple Myeloma Disease Progression In Vivo
 
 
Review

Article Versions Notes

Cancers 2020, 12(11), 3226; https://doi.org/10.3390/cancers12113226
Action Date Notes Link
article xml file uploaded 2 November 2020 06:34 CET Original file -
article xml uploaded. 2 November 2020 06:34 CET Update -
article pdf uploaded. 2 November 2020 06:34 CET Version of Record https://www.mdpi.com/2072-6694/12/11/3226/pdf-vor
article html file updated 2 November 2020 06:35 CET Original file -
article xml file uploaded 26 November 2020 11:44 CET Update -
article xml uploaded. 26 November 2020 11:44 CET Update https://www.mdpi.com/2072-6694/12/11/3226/xml
article pdf uploaded. 26 November 2020 11:44 CET Updated version of record https://www.mdpi.com/2072-6694/12/11/3226/pdf-vor
article pdf uploaded. 26 November 2020 11:45 CET Updated version of record https://www.mdpi.com/2072-6694/12/11/3226/pdf
article html file updated 26 November 2020 11:57 CET Update -
article html file updated 26 November 2020 11:57 CET Update -
article html file updated 22 July 2022 23:30 CEST Update https://www.mdpi.com/2072-6694/12/11/3226/html
Back to TopTop